← FDA Drug Approvals (Drugs@FDA)

OXCARBAZEPINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVAST LABS LTD · Approved 2025-06-04

Drug application

FDA Application #

ANDA218724

Application type

Abbreviated New Drug Application (Generic)

Brand name

OXCARBAZEPINE

Generic name

Oxcarbazepine

Active ingredients

OXCARBAZEPINE

Dosage form

TABLET, EXTENDED RELEASE

Route

—

Marketing status

None (Tentative Approval)

Sponsor

NOVAST LABS LTD

First approval

2025-06-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown